The pharmacology of choreatic movement disorders.
D000109:Acetylcholine / Q000378:metabolism; D000208:Acute Disease; D000661:Amphetamine / Q000627:therapeutic use; D002819:Chorea / Q000139:chemically induced / Q000150:complications / Q000188:drug therapy / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism; D006527:Hepatolenticular Degeneration / Q000150:complications; D006801:Humans; D006816:Huntington Disease / Q000175:diagnosis / Q000378:metabolism / Q000503:physiopathology; D006980:Hyperthyroidism / Q000150:complications; D007980:Levodopa; D008180:Lupus Erythematosus, Systemic / Q000150:complications; D009069:Movement Disorders / Q000139:chemically induced / Q000378:metabolism / Q000503:physiopathology; D012701:Serotonin / Q000378:metabolism; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D012701:Serotonin; D007980:Levodopa; D005680:gamma-Aminobutyric Acid; D000661:Amphetamine; D000109:Acetylcholine; D004298:Dopamine